| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 03:01:49 UTC |
|---|
| Update Date | 2022-11-30 19:25:57 UTC |
|---|
| HMDB ID | HMDB0114900 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(18:1(11Z)/16:1(9Z)) |
|---|
| Description | PA(18:1(11Z)/16:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(11Z)/16:1(9Z)), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCC\C=C/CCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCC InChI=1S/C37H69O8P/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-36(38)43-33-35(34-44-46(40,41)42)45-37(39)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h13-16,35H,3-12,17-34H2,1-2H3,(H2,40,41,42)/b15-13-,16-14-/t35-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-cis-Vaccenoyl-2-palmitoleoyl-sn-glycero-3-phosphate | HMDB | | 1-cis-Vaccenoyl-2-palmitoleoyl-sn-phosphatidic acid | HMDB | | PA(18:1/16:1) | HMDB | | PA(18:1N7/16:1N7) | HMDB | | PA(18:1W7/16:1W7) | HMDB | | PA(34:2) | HMDB | | Phosphatidic acid(18:1(11Z)/16:1(9Z)) | HMDB | | Phosphatidic acid(18:1/16:1) | HMDB | | Phosphatidic acid(18:1n7/16:1n7) | HMDB | | Phosphatidic acid(18:1W7/16:1W7) | HMDB | | Phosphatidic acid(34:2) | HMDB | | Phosphatidate(18:1(11Z)/16:1(9Z)) | HMDB | | Phosphatidate(18:1/16:1) | HMDB | | Phosphatidate(18:1N7/16:1N7) | HMDB | | Phosphatidate(18:1W7/16:1W7) | HMDB | | Phosphatidate(34:2) | HMDB | | [(2R)-2-[(9Z)-Hexadec-9-enoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphonate | HMDB | | 1-cis-vaccenoyl-2-palmitoleoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-cis-vaccenoyl-2-palmitoleoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(18:1/16:1) | SMPDB, HMDB | | PA(18:1n7/16:1n7) | SMPDB, HMDB | | PA(18:1w7/16:1w7) | SMPDB, HMDB | | PA(34:2) | SMPDB, HMDB | | Phosphatidic acid(18:1(11Z)/16:1(9Z)) | SMPDB, HMDB | | Phosphatidic acid(18:1/16:1) | SMPDB, HMDB | | Phosphatidic acid(18:1n7/16:1n7) | SMPDB, HMDB | | Phosphatidic acid(18:1w7/16:1w7) | SMPDB, HMDB | | Phosphatidic acid(34:2) | SMPDB, HMDB | | Phosphatidate(18:1(11Z)/16:1(9Z)) | SMPDB, HMDB | | Phosphatidate(18:1/16:1) | SMPDB, HMDB | | Phosphatidate(18:1n7/16:1n7) | SMPDB, HMDB | | Phosphatidate(18:1w7/16:1w7) | SMPDB, HMDB | | PA(18:1(11Z)/16:1(9Z)) | SMPDB |
|
|---|
| Chemical Formula | C37H69O8P |
|---|
| Average Molecular Weight | 672.925 |
|---|
| Monoisotopic Molecular Weight | 672.47300618 |
|---|
| IUPAC Name | [(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCC\C=C/CCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCC |
|---|
| InChI Identifier | InChI=1S/C37H69O8P/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-36(38)43-33-35(34-44-46(40,41)42)45-37(39)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h13-16,35H,3-12,17-34H2,1-2H3,(H2,40,41,42)/b15-13-,16-14-/t35-/m1/s1 |
|---|
| InChI Key | GLZNXLKBZKJBCJ-NAFNZUQFSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/16:1(9Z)) (PathBank: SMP0069926)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/18:1(11Z)) (PathBank: SMP0069928)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0069932)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0069934)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:2(9Z,12Z)/18:1(9Z)) (PathBank: SMP0069937)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)) (PathBank: SMP0069943)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)) (PathBank: SMP0069945)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0069946)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)) (PathBank: SMP0069948)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/18:1(9Z)) (PathBank: SMP0078658)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078662)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)) (PathBank: SMP0078683)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078686)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0078690)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z)) (PathBank: SMP0078692)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/18:1(11Z)) (PathBank: SMP0093929)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0093933)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0093935)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0093941)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0093942)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0093953)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0093963)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/16:1(9Z)) (PathBank: SMP0069916)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0069938)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) (PathBank: SMP0069954)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0078660)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/18:1(9Z)) (PathBank: SMP0078668)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:2(9Z,12Z)/16:1(9Z)) (PathBank: SMP0078674)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) (PathBank: SMP0078678)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) (PathBank: SMP0078679)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078695)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/16:0) (PathBank: SMP0093936)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/18:0) (PathBank: SMP0093938)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) (PathBank: SMP0093952)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(11Z)/18:2(9Z,12Z)) (PathBank: SMP0069919)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)) (PathBank: SMP0069950)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)) (PathBank: SMP0069955)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078672)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/18:2(9Z,12Z)/18:1(11Z)) (PathBank: SMP0093947)
- Cardiolipin Biosynthesis CL(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) (PathBank: SMP0069949)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/18:1(11Z)) (PathBank: SMP0016055)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/18:1(9Z)) (PathBank: SMP0016056)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0016057)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:1(11Z)) (PathBank: SMP0021798)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0021799)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/22:1(13Z)) (PathBank: SMP0021800)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/24:1(15Z)) (PathBank: SMP0021801)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0021802)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0021803)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/22:2(13Z,16Z)) (PathBank: SMP0021804)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0021805)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0021806)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0021807)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0021808)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0021809)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0021810)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0021811)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0021812)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:2(11Z,14Z)) (PathBank: SMP0033047)
- De Novo Triacylglycerol Biosynthesis TG(18:1(11Z)/16:1(9Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0033048)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.35 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 31.7665 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.95 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4823.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 456.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 330.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 219.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1002.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1646.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1224.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 258.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3262.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1052.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2620.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1214.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 673.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 540.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 774.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(18:1(11Z)/16:1(9Z)),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4737.4 | Semi standard non polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4183.9 | Standard non polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 5491.5 | Standard polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4675.8 | Semi standard non polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4158.0 | Standard non polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4714.4 | Standard polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4973.5 | Semi standard non polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 4285.4 | Standard non polar | 33892256 | | PA(18:1(11Z)/16:1(9Z)),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC | 5480.3 | Standard polar | 33892256 |
|
|---|